Positive sentiment towards BSX reflected in decline in short interest

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $5,231,670 were sold by Fitzgerald Joseph Michael on Aug 01 ’25. At $104.63 per share, Fitzgerald Joseph Michael sold 50,000 shares. The insider’s holdings dropped to 178,342 shares worth approximately $18.28 million following the completion of this transaction.

Also, Butcher Arthur C sold 17,313 shares, netting a total of over 1,811,520 in proceeds. Following the sale of shares at $104.63 each, the insider now holds 23,600 shares.

Before that, ARTHUR C BUTCHER had added 17,313 shares to its account. In a trade valued at $1,811,519, the Officer bought Boston Scientific Corp shares for $104.63 each.

As published in their initiating research note from Leerink Partners on June 16, 2025, Boston Scientific Corp [BSX] has been an Outperform and the price target has been revised to $118. Analysts at Needham upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of January 10, 2025, Deutsche Bank has increased its “Hold” rating to a “Buy” for BSX. Earlier on October 18, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for BSX stock which previously was a “a Buy”.

Analyzing BSX Stock Performance

On last trading session, Boston Scientific Corp [NYSE: BSX] plunged -0.14% to $102.5. The stock’s lowest price that day was $101.63, but it reached a high of $103.07 in the same session. During the last five days, there has been a drop of approximately -0.44%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 34.53%. Shares of the company reached a 52-week high of $108.94 on 07/23/25 and a 52-week low of $85.98 on 04/07/25.

Support And Resistance Levels for Boston Scientific Corp (BSX)

According to the 24-hour chart, there is a support level at 101.72, which, if violated, would cause prices to drop to 100.95. In the upper region, resistance lies at 103.17. The next price resistance is at 103.85. RSI (Relative Strength Index) is 42.71 on the 14-day chart, showing neutral technical sentiment.

Is Boston Scientific Corp subject to short interest?

Stocks of Boston Scientific Corp saw a sharp steep in short interest on 2025-07-31 dropping by -2.78 million shares to 16.27 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 19.05 million shares. A decline of -17.07% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.15 of the overall float, the days-to-cover ratio (short ratio) decline to 2.15.

Which companies own the most shares of Boston Scientific Corp (BSX)?

In terms of Boston Scientific Corp share price expectations, FactSet research, analysts set an average price target of 121 in the next 12 months, up nearly 17.89% from the previous closing price of $102.64. Analysts anticipate Boston Scientific Corp stock to reach 130 by 2025, with the lowest price target being 117. In spite of this, 15 analysts ranked Boston Scientific Corp stock as Buy at the end of 2025. On May 30, 2024, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $90.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.